GlObal Secondary Prevention strategiEs to Limit Event Recurrence After Myocardial Infarction. GOSPEL Study
Sponsor: Heart Care Foundation
A NA clinical study on Myocardial Infarction, this trial is completed. The trial is conducted by Heart Care Foundation and has accumulated 6 data snapshots since 2000. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.
Status Flow
Change History
6 versions recorded-
Sep 2025 — Present [monthly]
Completed NA
-
Sep 2024 — Sep 2025 [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Mar 2021 — Jul 2024 [monthly]
Completed NA
-
Jan 2021 — Mar 2021 [monthly]
Completed NA
▶ Show 1 earlier version
-
Jan 2017 — Jan 2021 [monthly]
Completed NA
First recorded
Dec 2000
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Heart Care Foundation
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
Ala, Italy , Aosta, Italy , Arco, Italy , Arenzano, Italy , Arezzo, Italy , Avellino, Italy , Bellano, Italy , Bergamo, Italy , Bologna, Italy , Bozzolo, Italy and 55 more locations